Romosozumab Prefilled Syringe [Evenity]

DRUG2 trials

Sponsors

Columbia University, Marmara University

Conditions

Osteoporosis in Post-menopausal WomenPremenopausal Idiopathic Osteoporosis

Phase 2

Romosozumab/Denosumab Study for Premenopausal IOP

Active, not recruitingNCT04800367

Columbia UniversityPremenopausal Idiopathic Osteoporosis

Start: 2021-03-12End: 2028-03-01Updated: 2026-02-27

Phase 4

Efficacy of Romosozumab and Denosumab Combined Treatment in Postmenopausal Osteoporosis Patients with Multiple Fragility Fractures

Not yet recruitingNCT06720350

Marmara UniversityOsteoporosis in Post-menopausal Women

Start: 2025-01-15End: 2026-12-15Target: 60Updated: 2024-12-27